Skip to main content
SpringerLink
Log in

Sleep and Sleep Disorders

  • Chapter
  • First Online:
Drug Abuse and Addiction in Medical Illness

  • 4543 Accesses

Abstract

Nearly all drugs of abuse and alcohol have considerable effects on sleep efficiency, sleep continuity, sleep stages, and consequent next-day alertness. It has been hypothesized that such drug effects on sleep and wake function may act as contributing factors in maintaining compulsive and excessive drug use, as well as factors that increase the risk for relapse. Alcohol at high doses disrupts sleep continuity and suppresses REM sleep. In abstinent alcoholics, a REM sleep disturbance is predictive of relapse. Stimulants, which have daytime alerting effects, have been shown to increase alertness and wakefulness at night, and suppress REM sleep. Analgesics have been found to decrease REM sleep and total sleep time, as well as increase daytime sleepiness. Hallucinogens have varying effects on sleep. MDMA has been shown to reduce sleep time without having major effects on REM sleep, whereas marijuana has been found to decrease REM sleep while increasing slow wave sleep. Older sedative-hypnotics like the barbiturates are also REM suppressant. In fact, virtually all drugs of abuse have REM suppressant properties, at least acutely. In contrast, the newer sedative-hypnotics (i.e., the benzodiazepine receptor agonists) which have a low abuse liability have been shown to have little effect on REM sleep.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stone BM. Sleep and low doses of alcohol. Electroencephalogr Clin Neurophysiol. 1980;48:706–9.

    Article  PubMed  CAS  Google Scholar 

  2. Roehrs T, Roth T. Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev. 2001;5:287–97.

    Article  PubMed  Google Scholar 

  3. Hyde M, Roehrs T, Roth T. Alcohol, alcoholism, and sleep. In: Lee-Chiong T, editor. Sleep: a comprehensive handbook. Philadelphia, PA: Wiley; 2006. p. 867–71.

    Google Scholar 

  4. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey I. Sleep. 2000;22:S347–53.

    Google Scholar 

  5. Roehrs T, Papineau K, Rosenthal L, Roth T. Ethanol as a hypnotic in insomniacs: self administration and effects of sleep and mood. Neuropsychopharmacology. 1999;20:279–86.

    Article  PubMed  CAS  Google Scholar 

  6. Roehrs, Blaisdell B, Cruz N, Roth T. Tolerance to hypnotic effects of ethanol in insomnias. Sleep. 2004;27:352 (ab).

    Google Scholar 

  7. Guilleminault C. Sleep apnea syndromes: impact of sleep and sleep states. Sleep. 1980;3:227–34.

    PubMed  CAS  Google Scholar 

  8. Issa FG, Sullivan CE. Alcohol, snoring and sleep apneas. J Neurol Neurosurg Psychiatry. 1982;45:353–9.

    Article  PubMed  CAS  Google Scholar 

  9. Mitler MM, Dawson A, Henriksen SJ, Sobers M, Bloom FE. Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res. 1988;12:801–5.

    Article  PubMed  CAS  Google Scholar 

  10. Herzog M, Riemann R. Alcohol ingestion influences the nocturnal cardio-respiratory activity in snoring and non-snoring males. Eur Arch Otorhinolarygol. 2004;261:459–62.

    Google Scholar 

  11. Aldrich MS, Shipley JE. Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res. 1993;17:192–6.

    Article  PubMed  CAS  Google Scholar 

  12. LeBon O, Verbanck P, Hoffmann G, et al. Sleep in detoxified alcoholics: impairment of most standard sleep parameters and increased risk for sleep apnea, but not for myclonias—a controlled study. J Stud Alcohol. 1997;58:30–6.

    CAS  Google Scholar 

  13. Brower KJ. Alcohol’s effects on sleep in alcoholics. Alcohol Res Health. 2001;25:110–25.

    PubMed  CAS  Google Scholar 

  14. Drummond SPA, Gillin JC, Smith TL, Demondena A. The sleep of abstinent pure primary alcoholic patients: natural course and relation to relapse. Alcohol Clin Exp Res. 1998;22:1796–802.

    PubMed  CAS  Google Scholar 

  15. Allen RP, Wagman AM, Funderburk FR, Well DT. Slow wave sleep: a predictor of individuals differences in response to drinking? Biol Psychiatry. 1980;15:345–8.

    PubMed  CAS  Google Scholar 

  16. Gillin JC, Smith TL, Irwin M, et al. Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry. 1994;51:189–97.

    Article  PubMed  CAS  Google Scholar 

  17. Arnedt JT, Conroy D, Rutt J, Aloia MS, Brower KJ, Armitage R. An open trial of cognitive-behavioral treatment for insomnia comorbid with alcohol dependence. Sleep Med. 2007;8:176–80.

    Article  PubMed  Google Scholar 

  18. Griffiths RR, Mumford GF. Caffeine—a drug of abuse? In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven; 1995. p. 1699–713.

    Google Scholar 

  19. Brezinova V. Effect of caffeine on sleep: EEG study in late middle age people. Br J Clin Pharmacol. 1974;1:203–8.

    Article  PubMed  CAS  Google Scholar 

  20. Karacan I, Thornby JI, Anch M, Booth GH, Williams RL, Salis PJ. Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther. 1977;20:682–9.

    Google Scholar 

  21. Nicholson AN, Stone BM. Heterocyclic amphetamine derivatives and caffeine on sleep. Br J Clin Pharmacol. 1980;9:195–203.

    Article  PubMed  CAS  Google Scholar 

  22. Okuma T, Matsuoka H, Matuse Y, Toyomura K. Model insomnia by methylphenidate and caffeine and use in the evaluation of temazepam. Psychopharmacology. 1982;76:201–13.

    Article  PubMed  CAS  Google Scholar 

  23. Bonnet MH, Arand DL. Caffeine use as a model of acute and chronic insomnia. Sleep. 1992;15:526–36.

    PubMed  CAS  Google Scholar 

  24. Gillin LC, Lardon M, Ruiz C, Golshan S, Salin-Pascual RJ. Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in non-smoking normal volunteers. J Clin Psychopharmacol. 1994;14:264–7.

    Article  PubMed  CAS  Google Scholar 

  25. Salin-Pascual RJ, de la Fuente JR, Galicia-Polo L, Drucker-Colin R. Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology. 1995;121:476–9.

    Article  PubMed  CAS  Google Scholar 

  26. Davila DG, Hurt RD, Offord KP, Harris CD, Shepard JW. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med. 1994;1560:469–74.

    Google Scholar 

  27. Prosise Gl, Bonnet MH, Berry RB, Dickel ML. Effects of abstinence from smoking on sleep and daytime sleepiness. Chest. 1994;105:1136–41.

    Google Scholar 

  28. Wetter DW, Fiore MC, Baker TB, Young TB. Tobacco withdrawal and nicotine replacement influence objective measures of sleep. J Consult Clin Psychol. 1995;63:658–67.

    Article  PubMed  CAS  Google Scholar 

  29. Phillips BA, Danner FJ. Cigarette smoking and sleep disturbance. Arch Intern Med. 1995;155:734–7.

    Article  PubMed  CAS  Google Scholar 

  30. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Gen Psychiatry. 1986;43:107–13.

    Article  CAS  Google Scholar 

  31. Kowatch RA, Schnoll SS, Knisely JS, Green D, Elswick RK. Electroencephalograpic sleep and mood during cocaine withdrawal. J Addict Disorders. 1992;11:21–45.

    Article  CAS  Google Scholar 

  32. Johanson CE, Roehrs T, Schuh K, Warbasse L. The effects of cocaine on mood and sleep in cocaine-dependent males. Exp Clin Psychopharm. 1999;4:338–46.

    Article  Google Scholar 

  33. Rechtschaffen A, Maron L. The effect of amphetamine on the sleep cycle. Electroencephalogr Clin Neurophysiol. 1964;16:438–45.

    Article  PubMed  CAS  Google Scholar 

  34. Mitler MM, Hajdukovic R, Erman MK. Treatment of narcolepsy with methamphetamine. Sleep. 1993;16:306–17.

    PubMed  CAS  Google Scholar 

  35. Watson R, Hartmann E, Schildkraut JJ. Amphetamine withdrawal: affective state, sleep patterns and MHPG excretion. Amer J Psychiat. 1972;129:262–9.

    Google Scholar 

  36. Nicholson AN, Stone BM. Stimulants and sleep in man. Agressologie. 1981;22:73–8.

    PubMed  CAS  Google Scholar 

  37. Braekeland F. The effect of methylphenidate on the sleep cycle in man. Psychopharmacologia. 1966;10:179–83.

    Article  Google Scholar 

  38. Tirosh E, Sadeh A, Munvez R, Lavie P. Effects of methylphenidate on sleep in children with attention-deficit hyperactivity disorder. Am J Dis Child. 1993;147:1313–5.

    PubMed  CAS  Google Scholar 

  39. Greenhill L, Puig-Antich J, Goetz R, Hanlon C, Davies M. Sleep architecture and REM sleep measures in prepubertal children with attention deficit disorder with hyperactivity. Sleep. 1983;6:91–101.

    PubMed  CAS  Google Scholar 

  40. Roehrs T, Papineau K, Rosenthal L, Roth T. Sleepiness and the reinforcing and subjective effects of methylphenidate. Exp Clin Psychopharm. 1999;7:145–50.

    Article  CAS  Google Scholar 

  41. Kay DC, Pickworth WB, Neidert GL. Morphine-like insomnia from heroin in non-dependent human addicts. Br J Clin Pharmacol. 1981;11:159–69.

    Article  PubMed  CAS  Google Scholar 

  42. Kay DC, Eisenstein RB, Jasinski DR. Morphine effects on human REM state, waking state, and NREM sleep. Psychopharmacologia. 1969;14:404–16.

    Article  PubMed  CAS  Google Scholar 

  43. Pickworth WB, Neidert GL, Kay DC. Morphine-like arousal by methadone during sleep. Clin Pharmacol Ther. 1981;30:796–804.

    Article  PubMed  CAS  Google Scholar 

  44. Kay DC. Human sleep during chronic morphine intoxication. Psychopharmacologia. 1975;44:117–24.

    Article  PubMed  CAS  Google Scholar 

  45. Mello NK, Mendelson JH, Lukas SE, Gastfriend DR, Teoh SK, Homan L. Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies. Harv Rev Psychiatry. 1993;1:168–83.

    Article  PubMed  CAS  Google Scholar 

  46. Griffiths RR, Weerts EM. Benzodiazepine self-administration in humans and laboratory animals. Implications for problems of long-term use and abuse. Psychopharmacology. 1997;134:1–37.

    Article  PubMed  CAS  Google Scholar 

  47. deWit H, Pierri J, Johanson CE. Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers. Pharm Biochem Behav. 1989;33:205–13.

    Google Scholar 

  48. deWit H, Uhlenhuth EH, Hedeker D, McCracken SG, Johanson CE. Lack of preference for diazepam in anxious volunteers. Arch Gen Psychiatry. 1986;43:533–41.

    Google Scholar 

  49. Oswald LM, Roache JD, Rhoades HM. Predictors of individual ­differences in alprazolam self-medication. Exp Clin Psychopharm. 1999;7:379–90.

    Article  CAS  Google Scholar 

  50. Roehrs T, Merlotti L, Zorick F, Roth T. Rebound insomnia and hypnotic self administration. Psychopharmacology. 1992;107:480–4.

    Article  PubMed  CAS  Google Scholar 

  51. Roehrs T, Pedrosi B, Rosenthal L, Zorick F, Roth T. Hypnotic self administration and dose escalation. Psychopharmacology. 1996;127:150–4.

    Article  PubMed  CAS  Google Scholar 

  52. Roehrs T, Pedrosi B, Rosenthal L, Zorick F, Roth T. Hypnotic self administration: forced-choice versus single-choice. Psychopharmacology. 1997;133:121–6.

    Article  PubMed  CAS  Google Scholar 

  53. Pivick RT, Zarcone V, Dement WC, Hollister LE. Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns. Clin Pharmacol Ther. 1972;13:426–35.

    Google Scholar 

  54. Freemon FR. The effect of delta-9-tetrahydrocannabinol on sleep. Psychopharmacologia. 1974;35:39–44.

    Article  CAS  Google Scholar 

  55. Barratt ES, Beaver W, White R. The effects of marijuana on human sleep patterns. Biol Psychiat. 1974;8:47–53.

    PubMed  CAS  Google Scholar 

  56. Feinberg I, Jones R, Walker JM, Cavness C, March J. Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man. Clin Pharmacol Ther. 1976;17:458–66.

    Google Scholar 

  57. Tassinari CA, Ambrosetto G, Peraita-Adrados MR, Gastaut H. The neuropsychiatric syndrome of delta-9-tetrahydrocannabinol and cannabis intoxication in naive subjects: a clinical and polygraphic study during wakefulness and sleep. In: Braude MC, Szara S, ­editors. The pharmacology of marijuana. New York: Raven; 1976. p. 357–82.

    Google Scholar 

  58. Babor TF, Mendelson JH, Kuehnle J. Marijuana and human physical activity. Psychopharmacology. 1976;50:11–9.

    Article  PubMed  CAS  Google Scholar 

  59. Chait LD. Subjective and behavioral effects of marijuana the morning after smoking. Psychopharmacology. 1990;100:328–33.

    Article  PubMed  CAS  Google Scholar 

  60. Karacan I, Fernandez-Salas A, Coggins WJ, Carter WE, Willians RL, Thornby JI, Salis PJ, Okawa M, Villaume JP. Sleep electroencephalographic-electrooculographic characteristics of chronic marijuana users: Part I. Ann NY Acad Sci. 1977;103:348–74.

    Google Scholar 

  61. Schmidt CJ, Levin JA, Lovenberg W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoamine systems in the rat brain. Biochem Pharmacol. 1987;36:747–55.

    Article  PubMed  CAS  Google Scholar 

  62. Allen RP, McCann UD, Ricaurte GA. Persistent effects of (±)3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) on human sleep. Sleep. 1993;16(6):560–4.

    PubMed  CAS  Google Scholar 

  63. Randall S, Johanson CE, Tancer M, Roehrs T. Effects of acute 3, 4-methylenedioxymethaphetamine on sleep and daytime sleepiness. Sleep. 2009;32(11):1513–9.

    PubMed  Google Scholar 

  64. Benca RM. Mood disorders. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005. p. 1311–26.

    Chapter  Google Scholar 

  65. Roehrs TA, Hyde M, Blaisdell B, Greenwalk M, Roth T. Sleep loss and REM sleep loss are hyperalgesic. Sleep. 2006;29:145–51.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sleep Disorders and Research Center, Henry Ford Health System, 2799 West Grand Blvd, CPF-3, Detroit, MI, 48202, USA

    Timothy Roehrs Ph.D. & Thomas Roth

  2. Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, Detroit, MI, USA

    Timothy Roehrs Ph.D. & Thomas Roth

Authors
  1. Timothy Roehrs Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy Roehrs Ph.D. .

Editor information

Editors and Affiliations

  1. Inst. Pharmaceutical Sciences, Department of Psychopharmacology, Utrecht University, Universiteitsweg 99, Utrecht, 3584CG, Netherlands

    Joris C. Verster

  2. Dept. Psychiatry, Medical University of South Carolina, President St. 67, Charleston, 29425, South Carolina, USA

    Kathleen Brady

  3. School of Medicine, Div. Alcoholism & Drug Abuse, New York University, First Ave. 550, New York, 10016, New York, USA

    Marc Galanter

  4. Institute of Psychiatry, King's College London, National Addiction Centre, Windsor Walk 4, London, SE5 8AF, United Kingdom

    Patricia Conrod

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Roehrs, T., Roth, T. (2012). Sleep and Sleep Disorders. In: Verster, J., Brady, K., Galanter, M., Conrod, P. (eds) Drug Abuse and Addiction in Medical Illness. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3375-0_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3375-0_30

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-3374-3

  • Online ISBN: 978-1-4614-3375-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation